Mirum (MIRM) Soars on Interim Data From Liver Disease Studies
Mirum Pharmaceuticals, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $96.33
+5.4% in 3d after detection
Post-detection moves
1h
—
1d
+0.2%
3d
+5.4%
7d
+4.3%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS